Snack producers are feeling the pressure to keep up with the growing consumer demand for healthier, more nutritionally rich, functional snacks, but adding functional ingredients isn't always as simple as it sounds
What this trial could tell us If results are positive, we would expect to see statistically significant differences between the resM group and placebo group in body weight, BMI, and relevant biomarkers like fasting glucose, insulin, and possibly GLP-1 levels
They can also help manage blood sugar levels, a critical aspect for individuals with type 2 diabetes
Investigating these pathways together allows researchers to explore how multi-receptor agonism affects systemic energy metabolism [5]
Price points themselves will also likely continue to shift
This triple action appears to make it more potent than existing treatments, though we're yet to see head-to-head comparison studies